CIK 0000728387
- Non-accelerated filer
- Smaller reporting company
Perspective Therapeutics, Inc.
Sign in to watch- Ticker
- CATX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411458152
- Phone
- +1 206-676-0900
- Business address
- 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
- Former names
- IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
- Open-market buys, last 90 days
- $128,390
- in 5 filings
- Open-market sales, last 90 days
- $1,622,534
- in 5 filings
Net −$1,494,144. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-21 | Cavanagh William Chief R&D Officer | Grant or award · Stock Options (right to buy) | +475,000 | 1,493,846 | ||
| 2021-07-01 | Cavanagh William Chief R&D Officer | Grant or award · Stock Options (right to buy) | +320,000 | 1,025,506 | ||
| 2020-10-22 | Cavanagh William Chief R&D Officer | Purchase | +7,692 | $0.52 | $4K | 27,692 |
| 2020-10-22 | Cavanagh William Chief R&D Officer | Purchase · Warrant (right to buy) | +3,846 | 705,506 | ||
| 2020-06-23 | Cavanagh William Chief R&D Officer | Grant or award · Stock Options (right to buy) | +150,000 | 701,660 | ||
| 2019-11-15 | Cavanagh William Chief R&D Officer | Purchase | +10,000 | $0.39 | $4K | 20,000 |
| 2019-06-18 | Cavanagh William Chief R&D Officer | Grant or award · Stock Options (right to buy) | +150,000 | 551,660 | ||
| 2018-11-16 | Cavanagh William COO, CSO | Purchase | +10,000 | $0.40 | $4K | 10,000 |
| 2018-06-13 | Cavanagh William COO, CSO | Grant or award · Stock Options (right to buy) | +150,000 | 401,660 | ||
| 2017-06-27 | Cavanagh William COO, CSO | Grant or award · Stock Options (right to buy) | +225,000 | 0 | ||
| 2017-06-15 | Cavanagh William COO, CSO | Returned to the company · Stock Options (right to buy) | −20,000 | 0 | ||
| 2017-06-15 | Cavanagh William COO, CSO | Returned to the company · Stock Options (right to buy) | −125,000 | 0 | ||
| 2016-06-21 | Cavanagh William COO | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2015-06-18 | Cavanagh William Vice President | Grant or award · Stock options | +20,000 | 20,000 | ||
| 2015-04-02 | Cavanagh William Vice President | Option exercise | +13,340 | $0.98 | $13K | 13,340 |
| 2015-04-02 | Cavanagh William Vice President | Sale | −13,340 | $1.53 | $20K | 0 |
| 2015-04-02 | Cavanagh William Vice President | Option exercise · Stock Options (right to buy) | −13,340 | 6,660 | ||
| 2014-06-17 | Cavanagh William Vice President | Grant or award · Stock Options | +20,000 | 20,000 | ||
| 2014-05-27 | Cavanagh William Vice President | Option exercise | +15,000 | $0.84 | $13K | 15,000 |
| 2014-05-27 | Cavanagh William Vice President | Option exercise | +15,571 | $0.99 | $15K | 30,571 |
Page 1 of 2 · 30 trades